JP2016501844A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501844A5
JP2016501844A5 JP2015540743A JP2015540743A JP2016501844A5 JP 2016501844 A5 JP2016501844 A5 JP 2016501844A5 JP 2015540743 A JP2015540743 A JP 2015540743A JP 2015540743 A JP2015540743 A JP 2015540743A JP 2016501844 A5 JP2016501844 A5 JP 2016501844A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound according
acceptable salt
compound
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2015540743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016501844A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/067466 external-priority patent/WO2014074365A1/en
Publication of JP2016501844A publication Critical patent/JP2016501844A/ja
Publication of JP2016501844A5 publication Critical patent/JP2016501844A5/ja
Ceased legal-status Critical Current

Links

JP2015540743A 2012-11-06 2013-10-30 MoGAT−2阻害剤として有用な新規のベンジルスルホンアミド化合物 Ceased JP2016501844A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12382431.0 2012-11-06
EP12382431 2012-11-06
US201361748935P 2013-01-04 2013-01-04
US61/748,935 2013-01-04
PCT/US2013/067466 WO2014074365A1 (en) 2012-11-06 2013-10-30 Novel benzyl sulfonamide compounds useful as mogat-2 inhibitors

Publications (2)

Publication Number Publication Date
JP2016501844A JP2016501844A (ja) 2016-01-21
JP2016501844A5 true JP2016501844A5 (enExample) 2016-11-24

Family

ID=47143796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015540743A Ceased JP2016501844A (ja) 2012-11-06 2013-10-30 MoGAT−2阻害剤として有用な新規のベンジルスルホンアミド化合物

Country Status (11)

Country Link
US (1) US9416138B2 (enExample)
EP (1) EP2917194B1 (enExample)
JP (1) JP2016501844A (enExample)
KR (1) KR20150063519A (enExample)
CN (1) CN104768941B (enExample)
AU (1) AU2013341584A1 (enExample)
BR (1) BR112015009567A2 (enExample)
CA (1) CA2886831A1 (enExample)
EA (1) EA201590696A1 (enExample)
MX (1) MX2015005739A (enExample)
WO (1) WO2014074365A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013112323A1 (en) 2012-01-23 2013-08-01 Eli Lilly And Company Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors
JP5852269B2 (ja) 2012-01-31 2016-02-03 イーライ リリー アンド カンパニー Mogat−2阻害剤として有用な新規モルホリニル誘導体
WO2017110841A1 (ja) * 2015-12-21 2017-06-29 塩野義製薬株式会社 Mgat2阻害活性を有する非芳香族複素環誘導体
TWI782056B (zh) 2017-07-14 2022-11-01 日商鹽野義製藥股份有限公司 具有mgat2抑制活性的縮合環衍生物
JP7608166B2 (ja) 2019-01-11 2025-01-06 塩野義製薬株式会社 Mgat2阻害活性を有するジヒドロピラゾロピラジノン誘導体

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2200981A1 (en) * 1994-10-04 1996-04-11 Hisashi Takasugi Urea derivatives and their use as acat-inhibitors
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
KR100922041B1 (ko) * 2002-01-29 2009-10-19 라보라토리스 세로노 에스.에이. 단백질 티로신 포스파타제의 모듈레이터로서의 치환된메틸렌 아미드 유도체
NZ550114A (en) * 2004-04-20 2011-02-25 Transtech Pharma Inc Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
EP1655283A1 (en) * 2004-11-08 2006-05-10 Evotec OAI AG 11beta-HSD1 Inhibitors
EP1659113A1 (en) 2004-11-08 2006-05-24 Evotec AG Inhibitors of 11beta-hydroxy steroid dehydrogenase type 1 (11beta-HSD1)
EP2078719A4 (en) 2006-09-28 2009-11-11 Dainippon Sumitomo Pharma Co COMPOUND WITH BICYCLIC PYRIMIDINE STRUCTURE AND THE COMPOUND CONTAINING PHARMACEUTICAL COMPOSITION
TW200831092A (en) * 2006-12-21 2008-08-01 Astrazeneca Ab Therapeutic agents
CA2751244A1 (en) * 2009-02-23 2010-08-26 Msd K.K. Pyrimidin-4(3h)-one derivatives
EP2243479A3 (en) * 2009-04-20 2011-01-19 Abbott Laboratories Novel amide and amidine derivates and uses thereof
WO2010123838A2 (en) * 2009-04-20 2010-10-28 Abbott Laboratories Novel amide and amidine derivatives and uses thereof
WO2013112323A1 (en) 2012-01-23 2013-08-01 Eli Lilly And Company Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors
JP5852269B2 (ja) 2012-01-31 2016-02-03 イーライ リリー アンド カンパニー Mogat−2阻害剤として有用な新規モルホリニル誘導体
AR089771A1 (es) 2012-01-31 2014-09-17 Lilly Co Eli Derivados de bencil sulfonamida utiles como inhibidores de mogat-2

Similar Documents

Publication Publication Date Title
JP2013537203A5 (enExample)
JP2017504635A5 (enExample)
JP2018529650A5 (enExample)
JP2013032389A5 (enExample)
JP2016530259A5 (enExample)
JP2015024998A5 (enExample)
JP2015537020A5 (enExample)
JP2016514159A5 (enExample)
JP2008531599A5 (enExample)
JP2016505614A5 (enExample)
JP2012508252A5 (enExample)
JP2016506958A5 (enExample)
JP2015509534A5 (enExample)
JP2015509535A5 (enExample)
JP2011518833A5 (enExample)
JP2016540742A5 (enExample)
JP2017501237A5 (enExample)
JP2015511232A5 (enExample)
JP2011513410A5 (enExample)
JP2015500842A5 (enExample)
JP2015521156A5 (enExample)
JP2016531126A5 (enExample)
JP2016501844A5 (enExample)
JP2017517538A5 (enExample)
JP2016507575A5 (enExample)